QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, April 18, 2007, 27(16):4403-4412; doi:10.1523/JNEUROSCI.5376-06.2007

This Article Full Text Full Text (PDF) Supplemental Data Submit an eLetter View eLetters for this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (24) Citing Articles via Google Scholar Google Scholar Articles by McColl, B. W. Articles by Allan, S. M. Search for Related Content PubMed PubMed Citation Articles by McColl, B. W. Articles by Allan, S. M. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Transient Ischemic Attack

 Previous Article  |  Next Article 

Neurobiology of Disease
Systemic Inflammatory Stimulus Potentiates the Acute Phase and CXC Chemokine Responses to Experimental Stroke and Exacerbates Brain Damage via Interleukin-1- and Neutrophil-Dependent Mechanisms

Barry W. McColl, Nancy J. Rothwell, and Stuart M. Allan

Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom

Correspondence should be addressed to Dr. Barry W. McColl, Faculty of Life Sciences, Michael Smith Building, University of Manchester, Manchester M13 9PT, UK. Email: barry.mccoll{at}manchester.ac.uk

Systemic inflammatory stimuli, such as infection, increase the risk of stroke and are associated with poorer clinical outcome. The mechanisms underlying the impact of systemic inflammatory stimuli on stroke are not well defined. We investigated the impact of systemic inflammation on experimental stroke and potential mechanisms involved. Focal cerebral ischemia was induced by intraluminal filament occlusion of the middle cerebral artery (MCAo). Brain damage and neurological deficit 24 h after MCAo were exacerbated by systemic lipopolysaccharide (LPS) administration. This exacerbation was critically dependent on interleukin (IL)-1, because coadministration of IL-1 receptor antagonist abolished the effect of LPS on brain damage. Systemic administration of IL-1 increased ischemic damage to a similar extent as LPS and also exacerbated brain edema. IL-1 markedly potentiated circulating levels of the acute phase proteins, serum amyloid A and IL-6, and the neutrophil-selective CXC chemokines, KC and macrophage inflammatory protein-2. Neutrophil mobilization and cortical neutrophil infiltration were aggravated by IL-1 before changes in ischemic damage. Neutropenia abolished the damaging effects of systemic IL-1. These data show for the first time that an acute systemic inflammatory stimulus is detrimental to outcome after experimental stroke and highlight IL-1 as a critical mediator in this paradigm. Our data suggest IL-1-induced potentiation of neutrophil mobilization via CXC chemokine induction is a putative mechanism underlying this effect. Our results may help to explain the poorer outcome in stroke patients presenting with infection and may have implications for neurodegenerative diseases involving neurovascular alterations, such as Alzheimer's disease, in which systemic inflammation can modulate disease progression.

Key words: cerebral ischemia; cytokine; infection; inflammation; leukocyte; lipopolysaccharide

---

Received Oct. 10, 2006; revised Feb. 21, 2007; accepted Feb. 22, 2007.

Correspondence should be addressed to Dr. Barry W. McColl, Faculty of Life Sciences, Michael Smith Building, University of Manchester, Manchester M13 9PT, UK. Email: barry.mccoll{at}manchester.ac.uk

This article has been cited by other articles:

				S. Serres, D. C. Anthony, Y. Jiang, K. A. Broom, S. J. Campbell, D. J. Tyler, S. I. van Kasteren, B. G. Davis, and N. R. Sibson Systemic Inflammatory Response Reactivates Immune-Mediated Lesions in Rat Brain J. Neurosci., April 15, 2009; 29(15): 4820 - 4828. [Abstract] [Full Text] [PDF]

				M. O. Breckwoldt, J. W. Chen, L. Stangenberg, E. Aikawa, E. Rodriguez, S. Qiu, M. A. Moskowitz, and R. Weissleder Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase PNAS, November 25, 2008; 105(47): 18584 - 18589. [Abstract] [Full Text] [PDF]

				B. W. McColl, N. J. Rothwell, and S. M. Allan Systemic Inflammation Alters the Kinetics of Cerebrovascular Tight Junction Disruption after Experimental Stroke in Mice J. Neurosci., September 17, 2008; 28(38): 9451 - 9462. [Abstract] [Full Text] [PDF]

				M. C. P. Godoy, R. Tarelli, C. C. Ferrari, M. I. Sarchi, and F. J. Pitossi Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease Brain, July 1, 2008; 131(7): 1880 - 1894. [Abstract] [Full Text] [PDF]

				M. Liu, Y. Liang, S. Chigurupati, J. D. Lathia, M. Pletnikov, Z. Sun, M. Crow, C. A. Ross, M. P. Mattson, and H. Rabb Acute Kidney Injury Leads to Inflammation and Functional Changes in the Brain J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1360 - 1370. [Abstract] [Full Text] [PDF]

				J.-M. Li, M. Mogi, J. Iwanami, L.-J. Min, K. Tsukuda, A. Sakata, T. Fujita, M. Iwai, and M. Horiuchi Temporary Pretreatment With the Angiotensin II Type 1 Receptor Blocker, Valsartan, Prevents Ischemic Brain Damage Through an Increase in Capillary Density Stroke, July 1, 2008; 39(7): 2029 - 2036. [Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

The Role of CXCL5 in Experimental Stroke

Issam Zineh

J. Neurosci. Online, 31 Oct 2007 [Full text]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help